Characterizing subgroups of type 2 diabetes at diagnosis for precision medicine.
Caracterización de Subgrupos de Diabetes Tipo 2 al diagnóstico: un Paso Necesario Hacia la Medicina de precisión en Diabetes.
This study is trying to find different types of newly diagnosed type 2 diabetes patients to better understand their unique needs and improve their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Academic / other |
| Locations | 2 sites (Barcelona, Catalunya and 1 other locations) |
| Trial ID | NCT05333718 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify and characterize subgroups of patients newly diagnosed with type 2 diabetes (T2DM) using six key variables. Conducted in primary care centers across Barcelona and Lleida, the study will enroll 1200 participants who will undergo a comprehensive phenotypic evaluation. The research will focus on understanding clinical, metabolic, and comorbid characteristics associated with these subgroups to enhance diagnostic precision in diabetes management.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who have been newly diagnosed with type 2 diabetes within the last three months.
Not a fit: Patients with other types of diabetes, such as type 1 or gestational diabetes, will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more personalized treatment strategies for patients with type 2 diabetes.
How similar studies have performed: Previous studies have successfully identified diabetes subgroups, suggesting that this approach has potential for meaningful insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects of both sexes, of legal age (≥18 years) * Newly diagnosed T2DM according to the criteria of the American Diabetes Association * With a maximum duration of three months of the disease at the time of inclusion. * Writen informed consent Exclusion Criteria: Subjects with a new diagnosis of other types of diabetes (type 1, MODY, gestational or other causes) will also be evaluated to ensure that the diagnostic criteria for selection are correctly implemented in all potential study participants. \*For final analysis, subjects with any diagnosis of diabetes other than T2DM will be excluded from the study.
Where this trial is running
Barcelona, Catalunya and 1 other locations
- Hospital of Santa Creu i Sant Pau — Barcelona, Catalunya, Spain (Not_yet_recruiting)
- Institut Català de la Salut — Barcelona, Catalunya, Spain (Recruiting)
Study contacts
- Principal investigator: Dídac Mauricio, MD, PhD — Hospital of Santa Creu i Sant Pau
- Study coordinator: Dídac Mauricio, MD, PhD
- Email: dmauricio@santpau.cat
- Phone: +34935565661
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.